Efficacy of generic sofosbuvir with daclatasvir compared to sofosbuvir/ledipasvir in genotype 4 hepatitis C virus: A prospective comparison with historical control-Reference-Cited by-同舟云学术

Efficacy of generic sofosbuvir with daclatasvir compared to sofosbuvir/ledipasvir in genotype 4 hepatitis C virus: A prospective comparison with historical control

Published:2022-12-08 Issue:1 Volume:6 Page:
ISSN:2398-8835
Container-title:Health Science Reports
language:en
Short-container-title:Health Science Reports

Author:

Joharji Hala¹^ORCID,Alkortas Delal¹,Ajlan Aziza¹^ORCID,Ahmed Mohamed¹,Al‐Ashgar Hamad²,Al‐Quaiz Mohammed²,Broering Dieter¹,Al‐Sebayel Mohammed³,Elsiesy Hussien³,Alkhail Faisal A.³,Al‐Hamoudi Waleed K.³,De Vol Edward⁴,Amirah Almuhayshir Epi⁴,Al‐Jedai Ahmed¹⁵⁶

Affiliation:

1. King Faisal Specialist Hospital and Research Centre Organ Transplant Center of Excellence Riyadh Saudi Arabia

2. Department of Medicine King Faisal Specialist Hospital and Research Centre Riyadh Saudi Arabia

3. Liver and Small Bowel Transplant and Hepatology Surgical Department King Faisal Specialist Hospital and Research Centre Riyadh Saudi Arabia

4. Biostatistics, Epidemiology and Science Computing Department King Faisal Specialist Hospital and Research Centre Riyadh Saudi Arabia

5. Therapeutic Affairs, Ministry of Health Riyadh Saudi Arabia

6. Alfaisal University Colleges of Medicine and Pharmacy Riyadh Saudi Arabia

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hsr2.980

Reference29 articles.

1. Applying a system approach to forecast the total hepatitis C virus-infected population size: model validation using US data

2. OPTN/SRTR 2012 Annual Data Report: Liver

3. Current Status and Future of Liver Transplantation

4. The association between hepatitis C infection and survival after orthotopic liver transplantation

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SASLT guidelines: Update in treatment of hepatitis C virus infection, 2024;Saudi Journal of Gastroenterology;2024-01

2. Monocytes subsets altered distribution and dysregulated plasma hsa-miR-21-5p and hsa-miR-155-5p in HCV-linked liver cirrhosis progression to hepatocellular carcinoma;Journal of Cancer Research and Clinical Oncology;2023-08-28

3. Monocytes Subsets Altered Distribution and Dysregulated Plasma hsa-miR-21-5p and hsa- miR-155-5p in HCV-Linked Liver Cirrhosis Progression to Hepatocellular Carcinoma;2023-03-01